Average Co-Inventor Count = 5.81
ph-index = 14
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (46 from 3,657 patents)
2. Vitae Pharmaceuticals, Inc. (25 from 84 patents)
3. Boehringer Ingelheim International Gmbh (10 from 1,522 patents)
4. Pliant Therapeutics, Inc. (7 from 15 patents)
5. Array Biopharma Inc. (3 from 328 patents)
6. Signal Pharmaceuticals, Inc. (3 from 169 patents)
7. Pharmacopeia Inc. (3 from 99 patents)
8. Other (2 from 831,952 patents)
9. Celgene Corporation (2 from 544 patents)
10. E.r. Squibb & Sons, Inc. (1 from 1,570 patents)
11. Vitae Pharamceuticals, Inc. (1 from 1 patent)
12. Pharmaceopeia, Inc. (1 from 1 patent)
13. Vitae Pharmaceuticals, Inc./boehringer-ingelheim (1 from 1 patent)
89 patents:
1. 12018025 - Integrin inhibitor and uses thereof
2. 11952376 - Substituted amino acids as integrin inhibitors
3. 11858931 - Amino acid compounds with unbranched linkers and methods of use
4. 11560376 - Amino acid compounds and methods of use
5. 11396506 - Amino acid compounds with unbranched linkers and methods of use
6. 11180494 - Substituted amino acids as integrin inhibitors
7. 11028093 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
8. 10793564 - Amino acid compounds and methods of use
9. 10730880 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as Janus kinase inhibitors
10. 10336717 - Inhibitors of beta-secretase
11. 10189845 - 4,6-substituted-pyrazolo[1,5-a]pyrazines as janus kinase inhibitors
12. 10144715 - Piperazine derivatives as liver X receptor modulators
13. 9814715 - Liver X receptor modulators
14. 9783505 - Substituted diaminopyrimidyl compounds, compositions thereof, and methods of treatment therewith
15. 9707232 - Liver X receptor modulators